Company Info

GSK

Overview

GSK is a fully focused biopharma company with a new purpose: to unite science, technology and talent to get ahead of disease together.

GSK prioritizes innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease. At the heart of this is their R&D focus on the science of the immune system, human genetics, and advanced technologies, and their world-leading capabilities in vaccine and medicines development. GSK’s four therapeutic areas of focus are infectious diseases, HIV, oncology, and immunology including respiratory diseases.

Contributors

Jamila Louahed, Ph.D.

Contributions

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

GSK Unveils Plan for One of Europe’s Largest Life Science Campuses in Stevenage

ViiV Healthcare and Halozyme Enter Global Collaboration for ENHANZE® Drug Delivery Technology to Enable Development of “Ultra Long-Acting” Medicines for HIV

Sanofi and GSK COVID-19 Vaccine Candidate Demonstrates Strong Immune Responses Across All Adult Age Groups in Phase 2 Trial

Lilly, Vir Biotechnology and GSK Announce Positive Topline Data From the Phase 2 Blaze-4 Trial Evaluating Bamlanivimab With Vir-7831 in Low-risk Adults With Covid-19

GSK to Support Manufacture of Novavax’ COVID-19 Vaccine

Sanofi and GSK to Support COVAX with 200 Million Doses of COVID-19 Vaccine

Avara Pharmaceutical Services Finalizes Acquisition of GSK Secondary Manufacturing and Packaging Facility in South Carolina

FDA Approves GSK’s BLENREP for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma